Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of Amlitelimab and BI 1015550 for Patients with Interstitial Lung Disease Due to Scleroderma

    Recruiting

    2 1
    Investigated Drugs:
    Austria Belgium Denmark France Germany Italy +5
  • A double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis

    Not yet recruiting

    3 1
    Investigated Diseases:
    Austria Belgium Bulgaria Czechia Denmark Estonia +14
  • Safety and efficacy of obinutuzumab in patients with active diffuse systemic sclerosis: a randomized, double-blind, placebo-controlled trial

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Safety and Efficacy of MTX-474 in Adults with Diffuse Cutaneous Systemic Sclerosis (dcSSc) – A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study

    Not yet recruiting

    2 1 1
    France Italy The Netherlands Poland Romania Spain
  • Study of CC-97540 (CD19‑Targeted NEX‑T CAR T) versus drug combination in adults with active systemic sclerosis

    Not yet recruiting

    3 1 1 1
    France Germany Italy Spain
  • Lebrikizumab in Adults with Moderate to Severe Localized Scleroderma

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Rituximab versus placebo for maintenance therapy in adults with stabilized systemic sclerosis‑associated interstitial lung disease

    Not yet recruiting

    4 1 1
    Investigated Drugs:
    France
  • A study to evaluate the safety and effectiveness of QEL-005 in patients with diffuse cutaneous systemic sclerosis and difficult to treat rheumatoid arthritis

    Not yet recruiting

    2 1 1
    Germany Spain
  • Comparing Dapagliflozin and Tocilizumab for Treating Patients with Systemic Sclerosis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Poland
  • Study of B Cell Response to Tetanus Toxoid Vaccination in Patients with Systemic Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    The Netherlands